Eden Research Share Discussion Threads

[chrischas] 07/7/2020 07:26

In the same building is a company supplying science boxes for schools...…
it would make a nice present for the BOD

[supersonico] 06/7/2020 22:19

Letting the right Rats in since May 2018

[chrischas] 06/7/2020 16:17

All they need to do now is get some rats for the lab.
Must have caught plenty when they left the old place.

At least they wont need a lab cleaner on the pay roll this year.

[supersonico] 04/7/2020 08:41

Investing, re your 7867 of 7875 post.

As you know I'm a strong believer in Bayer being a big part of Eden's future beyond CAP as they have been part of the in the coming short order parallel delay story now for over 7years.

The question for me is around how they work with the IP. This Bayer patent using terpenes / essential oils specifically excludes some of Eden's SustainE core ingredients which to me invites the question of why specifically exclude these oils? and how is Bayer going to use the volatile oils listed in it's products? and obviously another question is are they developing this with SustainE in mind.

A load of questions for those who follow the story but have no understanding of the chemistry so likely barking mad up the wrong tree.

METHODS OF INHIBITING, PREVENTING, KILLING AND/OR REPELLING INSECTS USING SIMULATED BLENDS OF CHENOPODIUM EXTRACTS

The present invention provides a spray formulation comprising as a single active ingredient a simulated combination of a Chenopodiumambrosioides essential oil extract similar to ambrosioid, wherein the simulated combination consists essentially of substantially pure α-terpinene, p-cymene and limonene, in which substantially pure means that each of α-terpinene, p-cymene and limonene contains less than or equal to 10% of other compounds, where each of substantially pure α-terpinene, p-cymene and limonene is not obtained from of a Chenopodium extract. The present invention provides compositions that comprise three terpenes, i.e. α-terpinene, p-cymene and limonene, as pesticide-active chemical compounds. The three terpenes in the compositions used in the present invention can be obtained, for example, from an extract of a genus / plant species other than Chenopodium 7 ambrosioides similar to ambrosioid, which produces such terpenes, or synthetically produced (that is, by a chemical synthesis process) , and / or as a compound naturally produced by any organism (that is, as a compound separated from an extract by itself).

In one embodiment, all three terpenes are from natural analogues of such terpenes as an extract from other plant species or other organisms. In yet another embodiment, all three terpenes are synthetic versions of Chenopodiumambrosioid terpenes obtainable similar to ambrosioides or other plant species or other organisms. In yet other embodiments, the three terpenes are any possible combination of natural and / or synthetic versions of the three terpenes. In another embodiment, the three terpenes are obtained from any source or by any means except a Chenopodiumambrosioidesou extract except a Chenopodium extract.

In one embodiment, the compositions comprise an excipient and a simulated combination consisting essentially of substantially pure α-terpinene, p-cymene and limonene not obtained from Chenopodium ambrosioides or not obtained from Chenopodium, where substantially pure means that each of α-terpinene, p-cymene and limonene contains less than or equal to 10% of other compounds. In another embodiment, the compositions consist essentially of an excipient and a simulated combination consisting essentially of substantially pure α-terpinene, p-cymene and limonene, where substantially pure means that each of entreα-terpinene, p-cymene and lemon contains less than or equal to 10% of other compounds.

In some embodiments, the compositions do not contain thymol, carvacol, carvone, carveol and / or nerol. In particular embodiments, the simulated combinations 8 in the above compositions are not a Chenopodium ambrosioides extract or a Chenopodium extract.

In another embodiment, the pesticide-active compositions of the present invention only include a synthetic combination that simulates the essential oil extract of or based on those found in Chenopodiumambrosioid-like ambrosioides. In still other embodiments, the compositions used in the methods of the present invention are reconstituted, as further explained here. In some embodiments, the simulated combinations comprise the three substantially pure α-terpinene, p-cymene and limonene, with at least one volume filler that replaces the volume occupied by the smaller components normally present in Chenopodium ambrosioid-like ambrosioid extract. In some embodiments, the volume filler is vegetable oil or mineral oil. In other embodiments, the simulated combinations essentially consist of α-terpinene, p-cymene and limonene, and an oil in which α-terpinene, p-cymene and limonene are substantially pure and are not obtained from an extract of Chenopodium, and the excipient is not an essential oil.

[supersonico] 03/7/2020 19:15

On Leaves TV we talk about 3LOGY and why it is "naturally effective" against botrite.




Corteva Secures Full Ownership of Phytogen Seed Company

[investingisatrickygame] 02/7/2020 08:16

Super,

I do remember that panel discussion very well.

Whether the Pro Farm and Eden deals with Corteva are related, I don't know, but it does show Corteva doing deals with small Agri-tech companies to improve their offering for a bio-led future

[supersonico] 02/7/2020 06:48

Investing
Some imagineering for you.

Corteva partnership with an interesting company who's patent 'Soluble fertilizer formulation and method for use thereof' might be enhanced by a complimentary technology that acts as a 'consolidator'.

Corteva and Pro Farm to develop biotech seed treatments



You will remember a panel that SS sat on a while back so the following related news may be of interest;


Marrone Bio Announces Closing of Pro Farm Technologies Acquisition.
New Subsidiary Enters into Strategic, Long-Term Exclusive Commercial Agreement in Europe with Corteva Agriscience

[erinvale] 01/7/2020 17:55

woolybanana

Because, even with new shiny offices, the company is worth zilch without sales.

[woolybanana] 01/7/2020 16:53

Why dont they buy the company?

[investingisatrickygame] 01/7/2020 16:27

Will Bayer who always have prominence in Eden presentations soon be collaborating or indeed using Eden's Sustaine and other technologies for their seed products?

It's about time Bayer became a commercial partner to Eden and not just a 'partner' as per the various presentations.

Hopefully, they will do.

[supersonico] 01/7/2020 14:36

Strong market growth for seed treatments and coatings boosted by biologicals

01 June 2020
Seed treatments are chemicals and/or biological products that are applied to the seed to protect them from early season diseases and pests. The discovery and introduction of systemic fungicides and insecticides revolutionized the use of seed treatments, as they not only protect the germinating seeds, but also the young seedlings. These include the ground-breaking fungicide from Bayer, Baytan (triadimenol) introduced in 1979 and the neonicotinoid insecticide, Gaucho (imidacloprid) introduced in 1994.

The total seed treatment market was valued at US$4.7 billion in 2018 and had a CAGR of 4.9% between 2012 and 2018. The seed treatment market is made up of chemicals and biologicals. The chemical segment dominates the market representing 93% of the total seed treatment market. However, the biological segment is the fastest growing with a CAGR of 8.4% between 2012 and 2018 (see Figure 1 below).

Technological advancements and increased understanding of plant physiological processes have played an important role in improving the efficacy and reliability of biological agents. Innovation in both chemicals and biologicals will continue to accelerate growth in the seed treatment market that is estimated to reach above $7 billion by 2025.

However, the regulatory environment is challenging and becoming more demanding, particularly in Europe which could constrain the market. In addition, a number of seed treatment active ingredients are off-patent and generic manufacturers have become key players in this market. Applying products to seeds rather than spraying them over the whole crop has numerous economic and environmental advantages. Many Biological Control Agents (BCAs) and biostimulants are particularly well-suited to being delivered this way.

The seed treatment market is dominated by Bayer and Syngenta who have a long history of developing seed treatment products. The recent consolidations in the agrochemical industry, ChemChina's acquisition of Syngenta, Bayer's acquisition of Monsanto and the formation of Corteva Agriscience (merger of Dow Agroscience, DuPont and Pioneer) have benefited other players seed treatment portfolios e.g. BASF and Nufarm.

In 2019, Bayer and Syngenta continued to dominate the market with a combined market share of 46%, with BASF holding a distinct third position with a market share of 15%. Other major players in the seed treatment market include Corteva, FMC, Nufarm, Sumitomo and UPL.

[weyweyumfozo] 01/7/2020 10:51

A bit of light relief regarding labs:

This looks like they are working on a product to get rid of mites on chickens:



Sides effects of Bunsonium being used as shampoo mentioned:

[erinvale] 01/7/2020 09:36

Great! New office - new consultants - new labs. All superficial flim-flam. How about some sales1

[chrischas] 01/7/2020 08:20

Good news but should have been done 3 or 4 years ago.Just like the government and civil service always too slow to react.I hope they know what they are going to do in their new lab.

[hillofwad] 01/7/2020 07:16

So hefty bill for relocation and fit outcosts expected No mention of any cost savings of rent

[supersonico] 01/7/2020 07:08

New office and laboratory in Oxfordshire

New laboratory facilities in Oxfordshire supports Eden's growth ambitions

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free encapsulation technology for use in global crop protection, animal health and consumer products industries, today announces that it has moved office and opened up a new laboratory facility at Milton Park, one of Europe's leading science and technology communities, located in Oxfordshire. The Company's registered office address has not changed.

The new laboratory facility will allow the Company to do more in-house, including formulation, microbiological screening, plant and seed evaluations and analytical work. It also features high-tech plant growth chambers, allowing Eden to undertake relatively rapid, small scale tests on different plant species. Eden also plans to use the laboratory for important insect-focussed work as part of the Company's plan to develop its first bioinsecticide products, which will allow the Company to enter new addressable markets valued at approximately €850m in the EU and US combined.

Milton Park is home to more than 250 companies and over 9,000 workers and is one of the largest science clusters in the country. The business community features cutting-edge science, technology and innovative businesses, making it a perfect fit for Eden to relocate as part of its strategic ambition to capitalise on new product and market opportunities.

Sean Smith, CEO of Eden Research, commented: "We are delighted to have been able to complete our office move on time and safely, in spite of the challenges posed by the Covid-19 pandemic. The opening of our new laboratory facilities is an important milestone for Eden. The fact that we now have the ability to conduct in-house research and development improves the efficiency of our operations, helping us to expand the footprint of our business through product development.

"Milton Park is well regarded for being home to some of the UK's top science and technology firms. We are excited to be joining the community and look forward to continuing our work in sustainable agriculture from our new Oxfordshire base."

[supersonico] 29/6/2020 11:49

It is good news and for me it's a strong confirmation/indicator of the direction of travel mentioned in the article I posted @ 7854 of 7859

[brucie5] 29/6/2020 11:05

Gr8t development in Mexico. I saw yesterday that on sustainablepulse. Promising also for EDEN given CEDROZ permission?

[sandcrab2] 29/6/2020 10:39

Why would Artemis throw in the towel at this point ?

[supersonico] 27/6/2020 17:53

Poster showing the key mergers and acquisitions that have occurred in the seed industry since 2000

[supersonico] 26/6/2020 18:44

Remember that fella who said Eden would become a big player in the biopesticide space.. and you thought... .well that's good, it's definitely growing but still pretty small by conventional standards.

Well have a look at this conclusion and then reconsider that statement with this in mind.


'Biologicals will replace a large portion of chemical crop-protection products and fertilizers, which together represent a market exceeding $240 billion. Biologicals will control pests, diseases, and weeds and fertilize crops directly all without harming beneficials, which in turn compounds their effectiveness. The widespread use of biologicals will revolutionize agriculture by triggering a resurgence in the residential beneficial populations that will control pests and diseases and make crops more resilient against biotic and abiotic crop stresses (e.g., heat, drought, and salinity during climate change) while increasing crop health and yields.

Stakeholders at every level will benefit from this revolution: Consumers will be assured that their food is grown safely and sustainably; farmers will have new tools for regenerative agriculture and a new income stream from sustainable services such as carbon sequestration as a means to combat climate change; and the industry will enjoy a large new market, which will guarantee a sustainable pipeline of future biologicals, thus more than replacing revenues lost due to declining chemical usage'.

[northwick] 26/6/2020 18:33

Hello SuperIf what you say is correct than it is quite disappointing that the share price hasn't shifted a gear.Until recently it was Artemis who held the share price back by selling in the market. Wonder who the new seller is?it's a pity that share register of major shareholders was last updated on 24/3/20 on Eden's website. Enjoy the weekend